Zach McLellan, Tara Hansen, Tom Tyler, and David Dahan discuss notable presentations and data releases from the 2020 ASCO meeting.

Topics covered in this episode include:

• TIGIT + PD-L1: tiragolumab w/ Tecentriq for NSCLC (0:45)
• Phase III ADAURA trial update: adjuvant Tagrisso for NSCLC (5:10)
• JAVELIN Bladder 100: Bavencio as maintenance therapy in urothelial carcinoma (10:00)
• TIVO-3: Final OS data unlikely to lead to US approval for Tivopath in RCC (14:27)
• Phase II Pevonedistat-2001 trial: pevonedistat for AML/MDS (19:05)
• Phase I/II EVOLVE study: orva-cel for multiple myeloma (25:05)
• CodeBreak 100: AMG 510 update (32:54)
• ADP-A2M4 SPEAR T-cells in solid tumors (38:45).